Please use this identifier to cite or link to this item:
Title: Proteomics technology and therapeutics
Authors: Hong, M.L.W.
Jiang, N.
Gopinath, S.
Chew, F.T. 
Keywords: Chromatographic techniques
Drug-discovery process
Mass spectrometry
Protein chips
Proteomics technologies
Two-dimensional gel electrophoresis
Issue Date: May-2006
Citation: Hong, M.L.W., Jiang, N., Gopinath, S., Chew, F.T. (2006-05). Proteomics technology and therapeutics. Clinical and Experimental Pharmacology and Physiology 33 (5-6) : 563-568. ScholarBank@NUS Repository.
Abstract: 1. Proteins are the workhorses of biological systems and, thus, it is not surprising that the field of proteomics has flourished in recent years. The present review briefly surveys the general proteomic approaches taken to identify drug targets and to evaluate drug efficacy and toxicity in the preclinical and clinical settings. These generally fall into three basic categories: a profiling approach, a functional approach and a structural approach. 2. The current 'tools' used and applied to the drug-discovery process will be highlighted. These include the two-dimensional gel electrophoresis, liquid chromatography, mass spectrometry, isotope-coded affinity tag and protein biochips. 3. Clearly, proteomics has begun to set a foothold in every stage of the drug-discovery process. Future developments in this area will likely make a significant impact in our quest for better, safer and cost-effective drugs. © 2006 Blackwell Publishing Asia Pty Ltd.
Source Title: Clinical and Experimental Pharmacology and Physiology
ISSN: 03051870
DOI: 10.1111/j.1440-1681.2006.04407.x
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on May 27, 2020


checked on May 19, 2020

Page view(s)

checked on May 30, 2020

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.